DMTweet: a psychedelic tweet recap

a PsyMed Ventures x Business Trip colab (issue #5)

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsement.

Let’s get to it….

Derek Thompson @DKThomp

In the last decade, sadness and anxiety has increased for every teenage demographic in every state. The level of sadness is highest for LGBT students, girls, and teens in California. The rate has increased most among white teens, boys, and seniors.

Petrie-Flom Center @PetrieFlom

Happening now: A Macro View of Microdosing. Join the conversation using #POPLAR and follow highlights in this 🧵petrieflom.law.harvard.edu/events/details…

petrieflom.law.harvard.eduA Macro View of Microdosing | Events | Petrie-Flom CenterView the conversationon Twitter @PetrieFlom using #POPLAR. We will share the fully captioned recording within 1-2 weeks. Event Description Microdosing psychedel

⬆️ click to read recap of the event ⬆️

Psilocybin Alpha @PsilocybinAlpha

BREAKING: Numinus $NUMI to Acquire Novamind $NM, Creating the North American Industry Leader in Psychedelic Therapy and Research

psilocybinalpha.comNuminus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research - Psilocybin AlphaComplementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory Shared mission of…

Joe Moore @jomo137

Do you think touch can be helpful in psychedelic assisted psychotherapy? I personally think in some scenarios it can be essential.

Michael Fulwiler @MichaelFulwiler

75% of people in substance abuse treatment report histories of abuse and trauma, yet most treatment programs don't address underlying trauma. This is a problem.

Christina Farr @chrissyfarr

We shouldn’t have universal health care because of wait lists, right? Meanwhile, in America… (A friend just sent me this after attempting to get a psychiatry appointment at UCSF)

Sam Altman @sama

The quality of psychedelic medicine companies (founders, approaches, scientists, etc) has dramatically increased in the past couple of years. Really excited for the impact this is going to have on mental health and happiness; I think it will be a pretty big step forward.

Richard E. Daws @neuroDaws

Just out in @NatureMedicine. Psilocybin therapy liberates the entrenched depressed brain by increasing the global integration of functional networks. It has been brilliant to collaborate w/ @RCarhartHarris @ProfDavidNutt et al.

nature.comIncreased global integration in the brain after psilocybin therapy for depression - Nature MedicineThe antidepressant response to psilocybin in individuals with treatment-resistant depression is distinct from escitalopram and depends on a global increase in brain network integration.

TechCrunch @TechCrunch

6 questions investors should ask when evaluating psychedelic biotech companies tcrn.ch/3uRN6IU by @matisere and @kubeans

tcrn.ch6 questions investors should ask when evaluating psychedelic biotech companies – TechCrunchWe believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.

Until next time,

Greg, Matias, and Dina

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.